Tumor targeting with a selective gelatinase inhibitor-Reference-Cited by-同舟云学术

Tumor targeting with a selective gelatinase inhibitor

Published:1999-08 Issue:8 Volume:17 Page:768-774
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Koivunen Erkki,Arap Wadih,Valtanen Heli,Rainisalo Aija,Medina Oula Penate,Heikkilä Pia,Kantor Carmela,Gahmberg Carl G.,Salo Tuula,Konttinen Yrjö T.,Sorsa Timo,Ruoslahti Erkki,Pasqualini Renata

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt0899_768.pdf

Reference52 articles.

1. Birkendal-Hansen, H. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7, 728–735 ( 1995).

2. Stetler-Stevenson, W.G., Aznavoorian, S. & Liotta, L.A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541–573 (1993).

3. Murray, G.I., Duncan, M.E., O'Neil, P., Melvin, W.T. & Fothergill, J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med. 2, 461–462 (1996).

4. Murphy, G. & Crabbe, T. Gelatinases A and B. Methods Enzymol. 248, 470–484 (1995).

5. Liotta, L.A. et al. Metastatic potential correlates with enzyme derived from a metastatic murine tumor. Nature 284, 67– 68 (1980).

Cited by 498 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A dual-action Rhein-peptide hydrogel synergistically inhibits inflammation and matrix degradation for therapeutic mitigation of abdominal aortic aneurysm;Chemical Engineering Journal;2024-10

2. Toxicity Studies of Cardiac-Targeting Peptide Reveal a Robust Safety Profile;Pharmaceutics;2024-01-04

3. Applications of the phage display technology in molecular biology, biotechnology and medicine;Critical Reviews in Microbiology;2023-06-04

4. Characterization of Active MMP9 in Chronic Inflammatory Diseases Using a Novel Anti-MMP9 Antibody;Antibodies;2023-01-18

5. Peptide-Based Therapeutics and Drug Delivery Systems;Drugs and a Methodological Compendium;2023